Researchers have showed that HIV does not cause acquired immune deficiency syndrome (AIDS) by the virus's direct effect on the host's immune cells, but rather through the cells' lethal influence on one another.
HIV can either be spread through free-floating virus that directly infect the host immune cells or an infected cell can pass the virus to an uninfected cell.
Cell to cell transmission, is 100 to 1000 times more efficient, and the study shows that it that sets off a chain reaction causes the newly infected cells committing suicide.
According to a previous research, 95 per cent of cell death from HIV is caused by immune cells committing suicide in self-defence after an unsuccessful infection.
When the virus tries to invade a cell that is "at rest," the infection is aborted. However, fragments of viral DNA remain and are detected by the resting host cell.
This triggers a domino effect in the cell's defence system, resulting in the activation of the enzyme caspase-1, which ultimately causes the induction of pyroptosis, a fiery form of cell suicide.
To confirm this finding, the researchers perturbed viral transfer through a number of means - genetically modifying the virus, blocking inter-cellular synapses, applying chemical HIV inhibitors, and increasing the physical distance between the cells so they could not come into contact with one another.
Disruption of cell-to-cell contact effectively stopped the death of CD4 T cells.
The scientists speculate that the difference in cell death rates between the two methods of infection is due to the increased efficiency of cell-to-cell transmission.
However, in cell-to-cell transmission, the viral DNA fragments overwhelm cell maintenance, building up until they surpass a threshold and are detected. This then triggers caspase-1 activation and pyroptosis.
"By preventing cell-to-cell transmission, we may able to block the death pathway and stop the progression from HIV infection to AIDS," said senior author Warner C Greene, director of the Gladstone Institute of Virology and Immunology.
The study was published in Cell Reports.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
